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Abstract 
Background: The survival predictors and optimal mechanical ventilator settings in patients with severe acute respira‑
tory distress syndrome (ARDS) undergoing extracorporeal membrane oxygenation (ECMO) are uncertain. This study 
was designed to investigate the influences of clinical variables and mechanical ventilation settings on the outcomes 
for severe ARDS patients receiving ECMO.
Methods: We reviewed severe ARDS patients who received ECMO due to refractory hypoxemia from May 2006 to 
October 2015. Serial mechanical ventilator settings before and after ECMO and factors associated with survival were 
analyzed.
Results: A total of 158 severe ARDS patients received ECMO were finally analyzed. Overall intensive care unit (ICU) 
mortality was 55.1%. After ECMO initiation, tidal volume, peak inspiratory pressure and dynamic driving pressure were 
decreased, while positive end‑expiratory pressure levels were relative maintained. After ECMO initiation, nonsurvivors 
had significantly higher dynamic driving pressure until day 7 than survivors. Cox proportional hazards regression 
model revealed that immunocompromised [hazard ratio 1.957; 95% confidence interval (CI) 1.216–3.147; p = 0.006], 
Acute Physiology and Chronic Health Evaluation (APACHE) II score (hazard ratio 1.039; 95% CI 1.005–1.073; p = 0.023), 
ARDS duration before ECMO (hazard ratio 1.002; 95% CI 1.000–1.003; p = 0.029) and mean dynamic driving pressure 
from day 1 to 3 on ECMO (hazard ratio 1.070; 95% CI 1.026–1.116; p = 0.002) were independently associated with ICU 
mortality.
Conclusions: For severe ARDS patients receiving ECMO, immunocompromised status, APACHE II score and the dura‑
tion of ARDS before ECMO initiation were significantly associated with ICU survival. Higher dynamic driving pressure 
during first 3 days of ECMO support was also independently associated with increased ICU mortality.
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Background
Acute respiratory distress syndrome (ARDS) is a het-
erogeneous syndrome with complex pathophysiologic 
mechanisms and has a high mortality rate up to 45% in 
severe ARDS [1]. A lung-protective ventilation strategy 
with lower tidal volume remains the cornerstone of treat-
ment for ARDS and is associated with improved survival 
[2]. Many alternative rescue treatments had been investi-
gated for ARDS with severe hypoxemia, but their impact 
on mortality is undetermined, except for early applica-
tion of prolonged prone position [3].
Although the survival benefit is not well established, 
extracorporeal membrane oxygenation (ECMO) may 
be a salvage therapy for severe ARDS patients with pro-
found hypoxemia refractory to conventional mechanical 
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ventilation [4–6]. For severe ARDS patients receiving 
ECMO support, the positive result of a multicenter ran-
domized controlled trial [7], favorable outcomes during 
the 2009 influenza A (H1N1) pandemic [8] and major 
advances in technology with less complication had 
allowed ECMO widespread application over the past 
decade [5, 9, 10]. However, the precise indications, opti-
mal timing to initiate and factors associated with mortal-
ity for severe ARDS patients who received ECMO were 
still not well established [4, 6, 9, 11].
ECMO facilitates an ultra-protective ventilation of 
more lowering delivered tidal volume and airway pres-
sure for resting the lungs. This ultra-protective lung 
strategy ideally may improve outcomes by further mini-
mizing ventilator-induced lung injury (VILI) [4, 6, 11–
16]. Although ECMO support limited stress and strain 
with ultra-protective ventilation, the specific extent of 
lung rest strategy and the optimal mechanical ventila-
tion settings targets during ECMO for severe ARDS 
patients remained uncertain [11–16]. There was no large 
multicenter prospective randomized controlled trial 
to address the optimal mechanical ventilation settings 
during ECMO in severe ARDS patients. In most clini-
cal practice, the mechanical ventilation settings during 
the ECMO depended on the clinicians’ experience [6]. 
A recent study from 3562 patients with ARDS enrolled 
in 9 previous reported randomized controlled trials con-
cluded that decreases in driving pressure were strongly 
associated with increased survival for patients with 
ARDS [17]. However, it is uncertain whether a similar 
association between driving pressure and survival exists 
for severe ARDS patients receiving ECMO.
The aim of this study was to investigate the influences 
of clinical variables and mechanical ventilation set-




This study was conducted in the medical and surgi-
cal ICUs at a tertiary care referral center, Chang Gung 
Memorial Hospital, with a 3700-bed general ward and a 
278-bed adult ICU. The local Institutional Review Board 
for Human Research approved this study (CGMH IRB 
No. 201600632B0), and the need for informed consent 
was waived due to the retrospective nature of the study.
We analyzed severe ARDS patients who received 
ECMO for refractory hypoxemia between May 2006 and 
October 2015. Severe ARDS was defined by the Ber-
lin definition with acute onset within 1  week, bilateral 
lungs opacities, no evidence of cardiac failure-related 
hydrostatic edema by echocardiography and PaO2/FiO2 
ratio <100 mmHg with positive end-expiratory pressure 
(PEEP) ≥5 cm H2O [1]. Exclusion criteria were: (1) age 
<20  years, (2) malignancies with poor prognosis within 
5  years and (3) significant underlying comorbidities or 
severe multiple organ failure refractory to treatment (4) 
mortality within 24 h after ECMO initiation. Before con-
sideration of ECMO initiation, all patients were sedated 
and ventilated with pressure-controlled ventilation using 
tidal volume of 6–8 ml/kg predicted body weight (PBW).
ECMO management and protocol
The decision to initiate ECMO was made by treat-
ing intensive care specialist when persistent hypox-
emia (PaO2/FiO2 ratio <80  mmHg) at least 6  h, despite 
aggressive mechanical ventilation support (PEEP  >  10 
cm H2O or peak inspiratory pressure >35 cm H2O). All 
patients were deeply sedated and paralyzed with continu-
ous neuromuscular blocking agent and ventilated with 
pressure-controlled ventilation until weaning attempt 
from ECMO. Initial mechanical ventilator settings pro-
tocol after ECMO support were as follows: tidal volume 
4–6 ml/kg PBW; PEEP 10–15 cm H2O; peak inspiratory 
pressure 25–30 cm H2O; respiratory rate 10–12 breaths 
per minute; and FiO2 adjusted to maintain arterial oxy-
gen saturation above 90%. The criteria for weaning from 
ECMO in our experience were resolving lungs infiltra-
tion, lung compliance >20 ml/cm H2O, PaO2 > 60 mmHg 
and PaCO2 < 45 mmHg under FiO2 ≦ 0.4, PEEP ≦ 6–8 cm 
H2O, and peak inspiratory pressure ≦30 cm H2O.
Data collection
The following data were collected from the hospital chart 
and analyzed: age, sex, body weight, body mass index, 
etiologies of ARDS, underlying diseases, Acute Physiol-
ogy and Chronic Health Evaluation (APACHE) II score, 
Sequential Organ Failure Assessment (SOFA) score and 
lung injury score on the day of ICU admission.
Arterial blood gas, ARDS duration before ECMO, ven-
tilator settings included tidal volume, respiratory rate, 
PEEP, peak inspiratory pressure, dynamic driving pres-
sure (the difference between peak inspiratory pressure 
and PEEP) and FiO2 were recorded before ECMO ini-
tiation. After ECMO support, daily arterial blood gas, 
ventilator settings, ECMO settings (gas flow, blood flow 
and FiO2) and ECMO complications (oxygenator failure, 
blood clots in oxygenator or circuit, bleeding, infection 
or others) were recorded until ICU discharge.
Statistical analyses
Continuous variables were presented as means ± stand-
ard deviation or median (interquartile range), and 
categorical variables were reported as numbers (percent-
ages). Student’s t test or the Mann–Whitney U test was 
used to compare continuous variables between survivors 
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and nonsurvivors, as appropriate. Categorical variables 
were tested using Chi-square test for equal proportion 
or Fisher’s exact test. Risk factors associated with ICU 
mortality were analyzed using Cox proportional haz-
ards regression model with stepwise selection procedure. 
All variables that were related to ICU mortality with a 
p  <  0.20 were finally introduced in the model. Calibra-
tion was assessed using Hosmer–Lemeshow goodness-
of-fit test (C statistic, goodness of fit was defined as a p 
value >0.05), and discrimination was assessed by the area 
under the receiver operating characteristics curve. Cut-
off points were calculated by obtaining the best Youden 
index (sensitivity  +  specificity  −  1). The results were 
presented as hazard ratio (HR) [95% confidence interval 
(CI)]. Cumulative survival curves as a function of time 
were generated using the Kaplan–Meier approach and 
compared using the log-rank test. All statistical analyses 
were performed with SPSS 21.0 statistical software. A p 
value <0.05 was considered significant.
Results
During the study period, 2622 patients were admit-
ted to our ICUs with a diagnosis of ARDS, of whom 
165 patients with severe ARDS receiving ECMO were 
included. A total of 158 patients were finally analyzed 
(Fig. 1). The overall ICU survival rate was 44.9%.
Details of the demographic data, clinical characteristics 
and ventilator settings before ECMO initiation between 
survivors and nonsurvivors are presented in Table 1. The 
main cause of ARDS was bacterial pneumonia, followed 
by viral pneumonia. Survivors were younger and had less 
immunocompromised and lower baseline APACHE II, 
SOFA scores than nonsurvivors. The duration of ARDS 
before ECMO initiation was significantly shorter in sur-
vivors than nonsurvivors. Mechanical ventilation settings 
and other ventilation parameters before ECMO support 
in two groups did not show significantly difference. Veno-
venous ECMO was used for 120 patients (75.9%), and 
other 38 patients received venoarterial ECMO with 11 
patients shifted to venovenous ECMO later. Venoarterial 
ECMO was performed for heart failure with intractable 
shock complicating ARDS-related diseases. The median 
duration of ECMO, ventilator, ICU and hospital stay were 
9 (5–15), 20 (12–38), 23 (13–43) and 39 (21–64) days, 
respectively. Overall, 43 (27.2%) patients had one or more 
ECMO-related complications with 4 patients died due to 
intracranial hemorrhage.
Mechanical ventilator settings after ECMO support
Daily arterial blood gas, mechanical ventilation settings 
were recorded, and we analyzed the data at 6  h, day 1, 
2, 3 and 7 after ECMO initiation. After ECMO support, 
tidal volume was reduced, but did not reveal significantly 
difference between survivors and nonsurvivors until 
day 7. After ECMO support 6  h, survivors had signifi-
cant higher PEEP level than nonsurvivors (12.6 ± 3.3 vs. 
11.4 ± 3.1 cm H2O, p = 0.02), but there was no difference 
until day 7. Both peak inspiratory pressure and dynamic 
driving pressure were decreased after ECMO initiation. 
Nonsurvivors had significantly higher peak inspiratory 
pressure after ECMO support day 2, day 3 and day 7 
(32.8 ± 6.4 vs. 30.6 ± 5.2 cm H2O, p = 0.02; 32.9 ± 6.8 
vs. 30.4 ± 6.0 cm H2O, p = 0.02; 33.1 ± 7.1 vs. 29.8 ± 5.7 
cm H2O, p =  0.01). Nonsurvivors also had significantly 
higher dynamic driving pressure after ECMO support 
until day 7 (all p < 0.05) (Table 1; Fig. 2).
Outcomes analysis
Cox proportional hazards regression model was used 
to identify variables that have prognostic value for 
ICU mortality (Table  2). Immunocompromised sta-
tus, APACHE II score, ARDS duration before ECMO 
and mean dynamic driving pressure from day 1 to 3 on 
ECMO remained independently associated with ICU 
mortality. Dynamic driving pressure with a cutoff point 
of 21 cm H2O exhibited the best Youden index, and mean 
dynamic driving pressure greater than 21 cm H2O from 
day 1 to 3 on ECMO was associated with higher mortal-
ity (HR 2.553; 95% CI 1.607–4.054; p  <  0.001; data not 
shown). Peak inspiratory pressure and SOFA score were 
not retained in the final model due to highly correlated 
with dynamic driving pressure and APACHE II score, 
respectively. Time to ECMO removal analysis and a land-
mark analysis excluding 7 patients who died in the first 
24  h after ECMO revealed that severe ARDS patients 
with mean dynamic driving pressure ≦21  cm H2O had 
significantly higher rate of ECMO removal than those 
with mean dynamic driving pressure >21 cm H2O from 
day 1 to 3 on ECMO (p = 0.017, log-rank test) (Fig. 3). 
The overall survival rate of severe ARDS patients with 
mean dynamic driving pressure ≦21  cm H2O was sig-
nificantly higher than those with mean dynamic driving 
pressure >21 cm H2O from day 1 to 3 on ECMO (56.1 vs. 
33.3%, p = 0.001, log-rank test) (Fig. 4).
Discussion
Our study analyzed the serial ventilator settings changes 
in severe ARDS patients after ECMO support and found 
that increased dynamic driving pressure during the first 
3 days was independently associated with higher mortal-
ity. In addition, immunocompromised status, APACHE II 
score and the duration of ARDS before ECMO initiation 
were also significantly associated with survival.
Amato and colleagues analyzed nine randomized con-
trolled trials in ARDS patients and concluded that driv-
ing pressure was most strong predictor of mortality [17]. 
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Recent study also demonstrated decreased respiratory 
system and transpulmonary driving pressure were asso-
ciated with improved 28-day mortality in ARDS patients 
[18]. A prospective multicenter study in 15 moderate 
ARDS patients with low-flow extracorporeal carbon 
dioxide removal (ECCO2R) demonstrated that driving 
pressure was significantly reduced during the first two 
days compared to baseline [19, 20]. However, the role 
of driving pressure on the severe ARDS patients requir-
ing ECMO was uncertain, and a clinical review recom-
mended that driving pressure is important determinant 
of outcome during ECMO [6]. The present study in 
severe ARDS patients receiving ECMO revealed that 
dynamic driving pressure from day 1 to 3 on ECMO was 
independently associated with mortality (Table 2).
Driving pressure was inversely proportional to compli-
ance of respiratory system and had two common defini-
tions: the difference between plateau pressure and PEEP 
and the difference between peak inspiratory pressure 
and PEEP [21]. There was no study compared differ-
ent modes of ventilation during ECMO, and pressure-
controlled mode appears to be advocated [12]. With 
pressure-controlled ventilation, pressure is maintained 
constant throughout inspiration, and flow decreases dur-
ing inspiration and is often followed by a period of zero 
flow at end inspiration. Peak inspiratory pressure and 
peak alveolar pressure (plateau pressure) may be equal 
during no flow status [22]. Therefore, we used the differ-
ence between peak inspiratory pressure and PEEP as cal-
culation of “dynamic” driving pressure. In fact, the most 
correct form can be obtained using transpulmonary driv-
ing pressure by esophageal manometry, but it is not easy 
to use in clinical practice. Reduction in dynamic driv-
ing pressure were found after ECMO initiation, and the 
values of survivors continued decreasing and exhibited 
significantly lower than nonsurvivors until day 7 (Fig. 2). 
Better lungs compliance and larger proportion of recov-
ered functional lung size could have benefitted the survi-
vors. Manipulation of driving pressure could be applied 
for ventilator management beside by adjusting the tidal 
volume and PEEP [18]. Although standardized ventila-
tion protocol for ARDS patients before and after ECMO 
was followed, it remains unclear from our observational 
study to definitely conclude that driving pressure was 
causally related to outcome or simply another marker for 
ARDS severity and it needed further randomized con-
trolled trials to confirm our findings.
Although ECMO facilitates the use of lung-protective 
ventilation, the optimal mechanical ventilation manage-
ment is unknown [4, 6, 11–14]. The lowering levels of 
plateau pressure and tidal volume have been related to 
decreased mortality [16]. Therefore, an ultra-protec-
tive ventilation strategy with low tidal volume reduc-
tion (<4  ml/kg, PBW), airway pressure reduction and 
Severe respiratory failure patients receiving ECMO (n=165)
Severe ARDS patients receiving ECMO (n=158)
Excluded:
Not meeting Berlin definition of ARDS (n=5)
Missing data (n=2)
Not weaned from ECMO (n=68)
Nonsurvivors (n=19)Survivors (n=71) Nonsurvivors (n=68)
Weaned from ECMO (n=90)
Fig. 1 Flowchart of severe acute respiratory distress syndrome (ARDS) patients receiving extracorporeal membrane oxygenation (ECMO)
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adequate PEEP was suggested to mitigate further VILI 
[4, 11–14]. Mechanical ventilation during ECMO may 
have an important impact on mortality. A cohort study 
of influenza A (H1N1)-induced ARDS patients receiv-
ing ECMO revealed that higher plateau pressure on the 
first day under ECMO was significantly associated with 
increased ICU mortality [23]. Another retrospective 
study demonstrated that higher PEEP levels during the 
first 3 days on ECMO were independently associated with 
lower ICU mortality [24]. A systemic review summarized 
Table 1 Characteristics of survivors and nonsurvivors of severe ARDS patients with ECMO support
Characteristic All patients (n = 158) Survivors (n = 71) Nonsurvivors (n = 87) p value
Age (years) 50.3 ± 16.3 46.0 ± 16.5 53.8 ± 15.4 0.003
Male (gender) 108 (68.4%) 48 (67.6%) 60 (69%) 0.855
Body weight (kg) 68.5 ± 16.7 70.1 ± 17.4 67.1 ± 16.1 0.268
Body mass index (kg/m2) 25.8 ± 5.2 26.0 ± 5.8 25.6 ± 4.7 0.656
ARDS etiologies
 Bacterial pneumonia 55 (34.8%) 19 (26.8%) 36 (41.4%) 0.055
 Viral pneumonia 24 (15.2%) 13 (18.3%) 11(12.6%) 0.327
 Nonpulmonary sepsis 21 (13.3%) 4 (5.6%) 17 (19.5%) 0.017
 Pulmonary contusion 19 (12%) 13 (18.3%) 6 (6.9%) 0.028
 Aspiration pneumonia 11 (7%) 8 (11.3%) 3 (3.4%) 0.066
 Other causes 28 (17.7%) 14 (19.7%) 14 (16.1%) 1.0
Comorbidities
 Diabetes mellitus 40 (25.3%) 23 (32.4%) 17 (19.5%) 0.065
 Cerebrovascular accident 10 (6.3%) 6 (8.5%) 4 (4.6%) 0.346
 Chronic heart diseasea 55 (34.8%) 23 (32.4%) 32 (36.8%) 0.565
 Chronic lung diseaseb 16 (10.1%) 4 (5.6%) 12 (13.8%) 0.115
 Chronic liver diseasec 22 (13.9%) 6 (8.5%) 16 (18.4%) 0.073
 Chronic kidney diseased 18 (11.4%) 8 (11.3%) 10 (11.5%) 0.964
 Immunocompromisede 42 (26.6%) 11 (15.5%) 31 (35.6%) 0.004
APACHE II score 23.4 ± 7.5 21.8 ± 8.0 24.7 ± 6.9 0.014
SOFA score 10.9 ± 3.2 10.3 ± 3.1 11.4 ± 3.2 0.042
Lung injury score 3.37 ± 0.44 3.44 ± 0.43 3.32 ± 0.45 0.085
ARDS duration before ECMO (h) 28.0 (7.0–129.0) 9.8 (3.7–64.0) 54.0 (16.0–200.0) <0.001
Pre‑ECMO ventilator settings
 PaO2/FiO2 (mmHg) 64 (52–87) 64 (53–80) 63 (52–107) 0.198
 Tidal volume (ml/kg PBW) 7.7 ± 2.4 7.7 ± 2.3 7.8 ± 2.4 0.753
 PEEP (cm H2O) 12.0 ± 2.8 12.2 ± 2.5 11.8 ± 3.0 0.319
 Peak inspiratory pressure (cm H2O) 33.9 ± 6.5 33.6 ± 6.0 34.1 ± 6.8 0.645
 Mean airway pressure (cm H2O) 18.7 ± 4.4 18.4 ± 4.2 18.9 ± 4.6 0.539
 Dynamic driving pressure (cm H2O) 21.9 ± 6.2 21.1 ± 5.8 22.6 ± 6.5 0.139
 Dynamic compliance (ml/cm H2O) 22.5 ± 11.2 23.4 ± 11.6 21.7 ± 10.9 0.366
Pre‑ECMO blood gas
 pH 7.28 ± 0.14 7.27 ± 0.12 7.28 ± 0.15 0.842
 PaCO2 (mmHg) 52.2 ± 18.8 50.7 ± 19.6 53.5 ± 18.2 0.359
 PaO2 (mmHg) 73.3 ± 39.3 71.6 ± 39.2 74.8 ± 39.6 0.617
 Saturation (%) 84.4 ± 15.9 84.7 ± 12.7 84.1 ± 18.2 0.804
Ventilator settings from day 1 to 3 on ECMO
 PaO2/FiO2 (mmHg) 178 (131–240) 200 (146–247) 165 (124–212) 0.588
 Tidal volume (ml/kg PBW) 6.0 ± 2.2 6.1 ± 2.0 6.0 ± 2.4 0.914
 PEEP (cm H2O) 12.0 ± 3.3 12.3 ± 3.2 11.7 ± 3.3 0.202
 Peak inspiratory pressure (cm H2O) 31.7 ± 5.6 30.6 ± 5.1 32.8 ± 5.9 0.018
 Mean airway pressure (cm H2O) 17.7 ± 4.0 17.4 ± 3.6 17.9 ± 4.3 0.406
 Dynamic driving pressure (cm H2O) 19.8 ± 6.3 18.3 ± 6.0 21.1 ± 6.4 0.006
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ventilation practices in ARDS patients with ECMO, and 
mortality was lower among patients who had lower ven-
tilation intensity following ECMO initiation [14]. Our 
present study found that pre-ECMO ventilator settings 
exhibited no significant difference. After ECMO initia-
tion, tidal volume, peak inspiratory pressure and dynamic 
driving pressure were all decreased, while PEEP lev-
els were relative maintained. Dynamic driving pressure 
Data are presented as mean ± standard deviation, count or median (interquartile range)
 APACHE Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, ECMO extracorporeal membrane oxygenation, FiO2 fraction of 
inspired oxygen, PaCO2 partial pressure of carbon dioxide in arterial blood, PaO2 partial pressure of oxygen in arterial blood, PBW predicted body weight, PEEP positive 
end-expiratory pressure, SOFA Sequential Organ Failure Assessment. Dynamic driving pressure: (peak inspiratory pressure—PEEP)
a Chronic heart disease included chronic heart failure, valvular heart disease, arrhythmia, hypertension and coronary artery disease
b Chronic lung disease included chronic obstructive pulmonary disease, interstitial lung disease, tuberculosis and bronchiectasis
c Chronic liver disease included chronic hepatitis and cirrhosis
d Chronic kidney disease included chronic renal insufficiency with creatinine level above 1.5 mg/dl
e Immunocompromised included hematological malignancies, solid tumors, sold organ transplantation, long-term steroid or immunosuppressant use and human 
immunodeficiency virus infection
Table 1 continued
Characteristic All patients (n = 158) Survivors (n = 71) Nonsurvivors (n = 87) p value
 Dynamic compliance (ml/cm H2O) 19.2 ± 8.1 21.1 ± 7.7 17.4 ± 8.1 0.006
Duration of ECMO (days) 9.0 (4.8–14.6) 8.7 (5.0–13.0) 9.8 (4.7–16.1) 0.696
ECMO complications 43 (27.2%) 16 (22.5%) 27 (31.0%) 0.232
Fig. 2 Serial changes in a tidal volume, b positive end‑expiratory pressure (PEEP), c peak inspiratory pressure and d dynamic driving pressure 
before and after extracorporeal membrane oxygenation (ECMO). Error bars represent the mean ± standard error. Dark line denotes survivors and 
gray line denotes nonsurvivors. *A value of p less than 0.05 compared between survivors and nonsurvivors
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during first 3 days of ECMO support was independently 
related to ICU mortality. Whether these mechanical set-
tings affected the outcome was not well known, and more 
Table 2 Cox proportional hazards regression model with ICU mortality as outcome
APACHE Acute Physiology and Chronic Health Evaluation, ARDS acute respiratory distress syndrome, CI confidence interval, ECMO extracorporeal membrane 
oxygenation, ICU intensive care unit, PEEP positive end-expiratory pressure. Dynamic driving pressure: (peak inspiratory pressure—PEEP)
Factors Hazard ratio (95% CI) p value
Univariate analysis
 Age 1.011 (0.998–1.025) 0.108
 Pulmonary contusion 0.417 (0.181–0.958) 0.039
 Aspiration pneumonia 0.405 (0.128–1.285) 0.125
 Diabetes mellitus 0.635 (0.373–1.083) 0.096
 Chronic liver disease 1.611 (0.931–2.788) 0.088
 Immunocompromised 1.731 (1.115–2.689) 0.015
 APACHE II score 1.032 (1.004–1.062) 0.027
 Lung injury score 0.596 (0.374–0.951) 0.030
 ARDS duration before ECMO 1.002 (1.001–1.003) 0.001
 Mean PEEP from day 1 to 3 on ECMO 0.942 (0.877–1.013) 0.106
 Mean dynamic driving pressure from day 1 to 3 on ECMO 1.052 (1.015–1.090) 0.005
 Mean dynamic compliance from day 1 to 3 on ECMO 0.971 (0.941–1.002) 0.069
Multivariate analysis
 Immunocompromised 1.957 (1.216–3.147) 0.006
 APACHE II score 1.039 (1.005–1.073) 0.023
 ARDS duration before ECMO 1.002 (1.000–1.003) 0.029
 Mean dynamic driving pressure from day 1 to 3 on ECMO 1.070 (1.026–1.116) 0.002
Fig. 3 Time to ECMO removal analysis in patients with severe acute 
respiratory distress syndrome (ARDS) on extracorporeal membrane 
oxygenation (ECMO). Blue line denotes patients with mean dynamic 
driving pressure ≦21 cm H2O, and green line denotes patients with 
mean dynamic driving pressure >21 cm H2O from day 1 to 3 on 
ECMO (p = 0.017)
Fig. 4 Kaplan–Meier survival curves in patients with severe acute 
respiratory distress syndrome (ARDS) on extracorporeal membrane 
oxygenation (ECMO). Blue line denotes patients with mean dynamic 
driving pressure ≦21 cm H2O, and green line denotes patients with 
mean dynamic driving pressure >21 cm H2O from day 1 to 3 on 
ECMO. The overall survival rate of patients with dynamic driving pres‑
sure ≦21 cm H2O was significantly higher than those with dynamic 
driving pressure >21 cm H2O (56.1 vs. 33.3%, p = 0.001)
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information will be obtained from an ongoing study in 
the future (SOLVE ARDS: Strategies for Optimal Lung 
Ventilation in ECMO for ARDS; clinicaltrials.gov identi-
fier NCT01990456).
Several studies had investigated the predictors of mor-
tality for severe ARDS patients treated with ECMO [10, 
23–27]. Our study found that the duration of ARDS, 
APACHE II score and immunocompromised status 
before ECMO were independently associated with ICU 
mortality. The optimal timing for ECMO initiation had 
not been established, and mechanical ventilation may 
cause substantial VILI even under lung-protective strat-
egy, which is worsened by delaying ECMO application 
for refractory hypoxemia [4, 13, 26–28]. Previous stud-
ies manifested duration of mechanical ventilation prior 
to ECMO support was correlated with mortality [10, 
24–27]. Our study found that survivors had significantly 
shorter ARDS duration before ECMO. Several studies 
reported that degree of systemic organ failure was cor-
related with outcome for ARDS patients before ECMO 
initiation [6, 24–26, 29, 30], and we found that APACHE 
II score was significantly associated with ICU mortality. 
Furthermore, recent report included 2355 patients with 
severe ARDS receiving ECMO from multiple countries 
over a 13-year period concluded that immunocompro-
mised status was independently associated with hos-
pital survival [10]. Immunocompromised status was 
independently associated with long-term outcomes form 
severe ARDS patients with ECMO [25]. Our study also 
found that immunocompromised status was significantly 
related to ICU mortality.
There were several limitations of our study. First, this 
study is a retrospective analysis in one referral medi-
cal center, which may limit the generalization to other 
ICUs or hospitals. Besides, there might be residual and 
unmeasured confounding variables not included in our 
study and other biases during long period of study from 
2006 to 2015 that could influence outcome. Second, 
APACHE II score was assessed only on the day of ICU 
admission and may not really reflect the dynamics of 
critical illness and treatment response. Serial evaluation 
of organ dysfunction during study period may be a bet-
ter predictor of prognosis. Third, early application of pro-
longed prone position for severe ARDS patients as rescue 
therapy had survival benefit, but only a small number of 
our patients (n  =  2) underwent prone position before 
ECMO. Finally, although ultra-protective ventilation 
strategy with ECMO based on a tidal volume reduction 
(<4 ml/kg, PBW), our study showed relatively higher tidal 
volume (around 6 ml/kg, PBW) after ECMO support.
Conclusions
Our study found that immunocompromised status, 
APACHE II score and the duration of ARDS before 
ECMO initiation were significantly associated with ICU 
survival in severe ARDS patients with ECMO. Dynamic 
driving pressure during first 3  days of ECMO support 
was also independently related to ICU mortality. Further 
large multicenter, prospective randomized controlled tri-
als are necessary to confirm the hypothesis that dynamic 
driving pressure could be a better predictor for survival 
in severe ARDS patients with ECMO support.
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